Company Filing History:
Years Active: 2020-2025
Title: Innovations by Raymond M. Russell
Introduction
Raymond M. Russell is an accomplished inventor based in Arcadia, CA (US). He has made significant contributions to the field of medical technology, particularly in the development of noninvasive glucose monitoring systems. With a total of 5 patents to his name, Russell's work is paving the way for advancements in diabetes management.
Latest Patents
Among his latest innovations are the miniaturized noninvasive glucose sensor and continuous glucose monitoring system. These patents describe techniques that involve a light emitter designed to emit light toward the skin of a person. The light emitter is controlled to emit light in pulses, which are crucial for generating acoustic waves in response to the emitted light. A resonance chamber is utilized to receive these acoustic waves, and a sensor is employed to detect them. The signal processor then estimates glucose concentration levels based on the sensed acoustic waves. The design of the resonance chamber is critical, as it is sized to form a standing wave that corresponds to the acoustic wavelength of interest when glucose analytes are present.
Career Highlights
Raymond M. Russell is currently associated with Medtronic Minimed, Inc., where he continues to innovate in the field of glucose monitoring. His work is instrumental in enhancing the accuracy and efficiency of glucose sensors, which are vital for individuals managing diabetes.
Collaborations
Russell has collaborated with notable colleagues, including James A. Reitz and Anthony C. Cannistraci. Their combined expertise contributes to the advancement of medical technologies and the development of effective solutions for glucose monitoring.
Conclusion
Raymond M. Russell's contributions to the field of medical technology, particularly in glucose monitoring, highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to enhancing the lives of individuals with diabetes through advanced technology.